Erratum (DOI:10.1016/j.tcm.2006.06.001);Histamine Network in Atherosclerosis

Trends in Cardiovascular Medicine

Volumn 16, Issue 8, 2006, Pages 280-284

  Tanimoto, Akihide ^a,b,c   Sasaguri, Yasuyuki ^a,b,c   Ohtsu, Hiroshi ^a,b,c  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b TORANOMON HOSPITAL   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FLUOROMETHYLHISTIDINE; ANTIHISTAMINIC AGENT; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H4 RECEPTOR; HISTIDINE DECARBOXYLASE; MEPYRAMINE;

ARTERY WALL; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE COURSE; GENE EXPRESSION; HISTAMINE METABOLISM; HISTOLOGY; HUMAN; INFLAMMATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW;

EID: 33750029918     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2006.12.001     Document Type: Erratum

References (41)

1. Atkinson J.B., Harlan C.W., Harlan G.C., et al. The association of mast cells and atherosclerosis: a morphologic study of early atherosclerotic lesions in young people. Hum Pathol 25 (1994) 154-159
2. Bissonnette E.Y. Histamine inhibits tumor necrosis factor alpha release by mast cells through H2 and H3 receptors. Am J Respir Cell Mol Biol 14 (1996) 620-626
3. Clemetson C.A. The key role of histamine in the development of atherosclerosis and coronary heart disease. Med Hypotheses 52 (1999) 1-8
4. Dale H.H., and Laidlaw P.P. Further observations on the action of b-imidazolylethylamine. J Physiol 43 (1911) 182-195
5. Dere E., De Souza-Silva M.A., Spieler R.E., et al. Changes in motoric, exploratory and emotional behaviours and neuronal acetylcholine content and 5-HT turnover in histidine decarboxylase-KO mice. Eur J Neurosci 20 (2004) 1051-1058
6. Dy M., and Schneider E. Histamine-cytokine connection in immunity and hematopoiesis. Cytokine Growth Factor Rev 15 (2004) 393-410
7. Fukui H., Fujimoto K., Mizuguchi H., et al. Molecular cloning of the human histamine H1 receptor gene. Biochem Biophys Res Commun 201 (1994) 894-901
8. Gantz I., Schaffer M., DelValle J., et al. Molecular cloning of a gene encoding the histamine H2 receptor. Proc Natl Acad Sci U S A 88 (1991) 429-433
9. Haas H., and Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4 (2003) 121-130
10. Higuchi M., Yanai K., Okamura N., et al. Histamine H(1) receptors in patients with Alzheimer's disease assessed by positron emission tomography. Neuroscience 99 (2000) 721-729
11. Higuchi S., Tanimoto A., Arima N., et al. Effects of histamine and interleukin-4 synthesized in arterial intima on phagocytosis by monocytes/macrophages in relation to atherosclerosis. FEBS Lett 505 (2001) 217-222
12. Hirasawa N., Ohtsu H., Watanabe T., et al. Enhancement of neutrophil infiltration in histidine decarboxylase-deficient mice. Immunology 107 (2002) 217-221
13. Huang M., Pang X., Letourneau R., et al. Acute stress induces cardiac mast cell activation and histamine release, effects that are increased in apolipoprotein E knockout mice. Cardiovasc Res 55 (2002) 150-160
14. Igaz P., Novak I., Lazaar E., et al. Bidirectional communication between histamine and cytokines. Inflamm Res 50 (2001) 123-128
15. Jutel M., Watanabe T., Akdis M., et al. Immune regulation by histamine. Curr Opin Immunol 14 (2002) 735-740
16. Jutel M., Blaser K., and Akdis C.A. Histamine in allergic inflammation and immune modulation. Int Arch Allergy Immunol 137 (2005) 82-92
17. Kimura S., Wang K.Y., Tanimoto A., et al. Acute inflammatory reactions caused by histamine via monocytes/macrophages chronically participate in the initiation and progression of atherosclerosis. Pathol Int 54 (2004) 465-474
18. Koarai A., Ichinose M., Ishigaki-Suzuki S., et al. Disruption of L-histidine decarboxylase reduces airway eosinophilia but not hyperresponsiveness. Am J Respir Crit Care Med 167 (2003) 758-763
19. Krishnaswamy G., Kelley J., Yerra L., et al. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res 19 (1999) 91-104
20. Kume N., and Kita T. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in atherogenesis. Trends Cardiovasc Med 11 (2001) 22-25
21. Laszlo V., Rothe G., Hegyesi H., et al. Increased histidine decarboxylase expression during in vitro monocyte maturation; a possible role of endogenously synthesised histamine in monocyte/macrophage differentiation. Inflamm Res 50 (2001) 428-434
22. Lovenberg T.W., Roland B.L., Wilson S.J., et al. Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 55 (1999) 1101-1107
23. MacGlashan Jr. D. Histamine: a mediator of inflammation. J Allergy Clin Immunol 112 (2003) S53-S59
24. Majno G., and Palade G.E. Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol 11 (1961) 571-605
25. Makabe-Kobayashi Y., Hori Y., Adachi T., et al. The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxis. J Allergy Clin Immunol 110 (2002) 298-303
26. Masaki T., Chiba S., Yasuda T., et al. Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity. Diabetes 53 (2004) 2250-2260
27. Miyazawa N., Watanabe S., Matsuda A., et al. Role of histamine H1 and H2 receptor antagonists in the prevention of intimal thickening. Eur J Pharmacol 362 (1998) 53-59
28. Moya-Garcia A.A., Medina M.A., and Sanchez-Jimenez F. Mammalian histidine decarboxylase: from structure to function. Bioessays 27 (2005) 57-63
29. Oda T., Morikawa N., Saito Y., et al. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 275 (2000) 36781-36786
30. Ohtsu H., Tanaka S., Terui T., et al. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett 502 (2001) 53-56
31. Parmentier R., Ohtsu H., Djebbara-Hannas Z., et al. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 22 (2002) 7695-7711
32. Sasaguri Y., Wang K.Y., Tanimoto A., et al. Role of histamine produced by bone marrow-derived vascular cells in pathogenesis of atherosclerosis. Circ Res 96 (2005) 974-981
33. Satoh T., Sugama K., Matsuo A., et al. Histamine as an activator of cell growth and extracellular matrix reconstruction for human vascular smooth muscle cells. Atherosclerosis 110 (1994) 53-61
34. Schneider E., Rolli-Derkinderen M., Arock M., et al. Trends in histamine research: new functions during immune responses and hematopoiesis. Trends Immunol 23 (2002) 255-263
35. Takagishi T., Sasaguri Y., Nakano R., et al. Expression of the histamine H1 receptor gene in relation to atherosclerosis. Am J Pathol 146 (1995) 981-988
36. Takahashi K., Suwa H., Ishikawa T., et al. Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype. J Clin Invest 110 (2002) 1791-1799
37. Tanimoto A., Murata Y., Nomaguchi M., et al. Histamine increases the expression of LOX-1 via H2 receptor in human monocytic THP-1 cells. FEBS Lett 508 (2001) 345-349
38. Vannier E., Miller L.C., and Dinarello C.A. Histamine suppresses gene expression and synthesis of tumor necrosis factor alpha via histamine H2 receptors. J Exp Med 174 (1991) 281-284
39. Wang K.Y., Arima N., Higuchi S., et al. Switch of histamine receptor expression from H2 to H1 during differentiation of monocytes into macrophages. FEBS Lett 473 (2000) 345-348
40. Yokoyama H. The role of central histaminergic neuron system as an anticonvulsive mechanism in developing brain. Brain Dev 23 (2001) 542-547
41. Young J.L., Libby P., and Schonbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 88 (2002) 554-567